L’Oréal: New 52-Week Low, but Fears on China Likely Misplaced
Company Update (OR FP) (Buy): Shares are a good defensive asset, with a reasonable valuation, solid long-term EPS growth and minimal capital risk.
Highlights
Shares are back to Jan-23 levels and at ~30x 2023 EPS (likely ~28x 2024).
H1 results showed sales growing 7%+; EPS growth looks worse due to M&A.
Sales growth was broad-based and in spite of a market decline in China.
L’Oréal expects H2 to be similar; China sales are now smaller than EM’s.
At €365.90, we see a 54% total return (14.4% p.a.) by end of 2027. Buy.
Introduction
We review our Buy rating on L’Oréal after shares have recently fallen to a new 52-week low; the share price is now 9.5% lower than a year ago and back to levels last seen in January 2023:
L’Oréal Share Price (Last 5 Years)
Source: Google Finance (16-Sep-24).
We have added L’Oréal as a small position in our “Select 15” model portfolio this month. Before that, we last published research on L’Oréal in April, after a gap of nearly a year; L’Oréal shares have fallen 9.7% since our April article, largely due to investor concerns about a weak beauty market in China and a possible slowdown in the U.S. in our opinion.
We continue to believe L’Oréal shares represent a good defensive investment, with annualized returns almost certain to exceed 10% annually over time and minimal capital risks.
(The rest of this article is for paid subscribers only, but unlocking it costs just $10; you can see a free sample of our research here.)